A cohort study on patient-reported outcomes (PRO) in patients with lifestyle disease who have used Welby My-Karte

A cohort study on patient-reported outcomes (PRO) in patients with lifestyle disease who have used Welby My-Karte - e-PROMIS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039658

Enrollment

1000

Registered

2020-03-02

Start date

2020-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Those with a lifestyle disease (diabetes, hypertension, or hyperlipidemia)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who fulfill the following criteria: - Those with a lifestyle disease (diabetes, hypertension, or hyperlipidemia) diagnosed six months or more before participation in the present study, or those who have smoking habits (including electronic cigarettes and heated tobacco products) for six months or more before participation in the present study - Those who have been receiving drug therapy for diabetes, hypertension, or hyperlipidemia for six months or more at the medical institution participating in the present study - Those who had used Welby My-Karte before participation in the present study (regardless of whether they use it or not when they participate in the present study) and those who started using it before December 31, 2019 (the start date refers to the date when they are registered as users.) - Those aged 40 years or more - Those who provide written consent to participation in the present study

Exclusion criteria

Exclusion criteria: Those who meet any of the following criteria: - Those who the principal investigator or sub-investigator considers to have other serious diseases - Those who the principal investigator or sub-investigator considers to be ineligible for the present study - Those with type 1 diabetes

Design outcomes

Primary

Measure	Time frame
1) The continuation rate 2) The duration of use: the mean duration of use and the distribution of the duration of use 3) The reasons for discontinuation	—

Secondary

Measure	Time frame
- Subject characteristics - Results of a questionnaire survey conducted at enrollment - Retrospective data - Prospective data - Condition of subjects at the end of screening	—

Countries

Japan

Contacts

Public ContactYuko Ishikawa

Satt Co., Ltd Clinical research group

e-promis@sa-tt.co.jp03-5312-5026

Outcome results